has decided to embark on the path of fine-tuning and developing rhNGF in its formulation for clinical use, at its own biotech facility in L’Aquila. and in Naples, where there are the laboratories of Drug Discovery and Technology Formulation, within a long-term collaboration with CNR. Italian excellence: the Dompé Hub in L’Aquila. Dompé has concentrated its manufacturing and research and development activities at its L’Aquila hub.
||21 February 2011
|PDF File Size:
|ePub File Size:
||Free* [*Free Regsitration Required]
The hub employs 70 researchers and now, thanks to the special technical and scientific skills accumulated over the years, the facility is able to cover the entire Drug Discovery process, from the initial research stages up to final clinical development.
The product was granted additional orphan drug designation for the treatment of neurotrophic keratitis in the U. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 30 year tenure till date DecAround 35 plus products in his career.
An endeavour that starts out thanks to the research of Nobel Prize winner Rita Levi Montalcini, for the development and production of potential biotechnological drugs for the treatment of rare eye diseases. One group received Oxervate, a second group received an eye drop with a different concentration of cenegermin, and the third group received an eye drop without cenegermin.
The activity includes every stage of development, from refinement of the experimental design for creating the drug, to the identification of creative, innovative and flexible solutions that could lead to industrial production. This phase is followed by packaging in boxes, wrapping and pallets. For information, including how to block the cookies, click here. Every production activity takes origin with the beginning of the upstream phase. Radhakrishnan and Dr B. NGF was the first neurotrophic factor to be identified and purified and over the last fifty years, its role in neuronal development and its biological activity on neural tissue has been of great interest to science.
The production of liquids refers to the two lines of formulation and packaging known as small and large volume. This study is aimed at assessing the safety and the efficacy of two dose regimens of recombinant human nerve growth factor rhNGF eye drops solution compared to vehicle for inducing a complete healing of stage 2 persistent epithelial defect and 3 corneal ulcer neurotrophic keratitis.
Medical Affairs is the medical-scientific benchmark of excellence when it comes to the production and disclosure of clinical data.
Given its importance, the cell bank is also stored off-site, so as to guarantee its preservation in case of natural disasters. The division works in close connection with the scientific community to make safe drugs available to patients that can meet their therapeutic needs.
The collaborations in the territory have the objective of creating new knowledge and developing suitable expertise for the profound technological and innovative transformation that is revolutionizing the health sector worldwide. All eye drops in both studies were given six times daily in the affected eye s for eight weeks.
DOMPE « New Drug Approvals
For information, including how to block the cookies, click here. For information, including how to block the cookies, click here.
Sorry, your blog cannot share posts by email. The chemokine CXCL8 plays a key role in the recruitment and activation of polymorphonuclear neutrophils in post-ischemia reperfusion injury after organ transplantion.
The entire upstream process is carried out in controlled environments that guarantee sterility and bacterial containment. The prevalence of neurotrophic keratitis has been estimated to be less than five in 10, individuals. We suggest you to update it for free by following one of the these links, choosing the browser you prefer: The BF unit works mainly in the field of ophthalmology with the aim of optimising the periocular and intraocular release of proteins, for the treatment of rare diseases.
The activities being implemented included continuous control, through a monitoring network consisting of 1, elements SCADA that monitor the areas and production facilities. August 23, 9: Cenegermin is a human beta-nerve growth factor beta-ngf – – peptide non-covalent dimer produced in escherichia coli.
Reparixin is the first low molecular weight blocker of CXCL8 biological activity in clinical development. In the first part of the downstream process, the inclusion bodies, coming from the upstream phase, are solubilised and then the folding phase starts. The procedure consists of generating a genetic carrier plasmid containing the gene able to express the protein proNGF, protein precursor of the mature protein NGF.
The aim is to convey all the metabolic energy of the bacterium with a solely reproductive aim. This site uses third party cookies.
The protein—in this case Nerve Growth Factor, NGF —is produced using a living organism the bacterium Escherichia Coli of which the entire genome and the complex of biological interactions is known in detail.